South Africa may swap or sell ‘less effective’ AstraZeneca COVID-19 vaccine — Minister

The government of South Africa has hinted that the ‘less effective’ Oxford-AstraZeneca vaccine against the dreaded COVID-19 virus may be swapped or sold to countries in need of the jab.

This was revealed in a statement issued on Wednesday by South Africa’s Health Minister, Zweli Mkhize who said that the country has one and half million doses of the AstraZeneca vaccine.

“There are already some countries that are asking that we must sell it to them,” Mkhize told a news conference yesterday.

READ ALSO: Concerns raised in South Africa over effectiveness of new COVID-19 vaccine

“Our scientists will continue with further deliberations on the AstraZeneca vaccine used in South Africa and depending on their advice, the vaccine will be swapped before the expiry date.”

This came days after South Africa ordered the suspension of the use of the AstraZeneca vaccine developed in conjunction with the University of Oxford, in its ongoing immunisation programme.

This was contained in a statement issued on Sunday by Mkhize who said that the suspension of the use of the Oxford/AstraZeneca coronavirus vaccine will remain until a committee of scientists advises on the best way to proceed.

Join the conversation

Opinions

Support Ripples Nigeria, hold up solutions journalism

Balanced, fearless journalism driven by data comes at huge financial costs.

As a media platform, we hold leadership accountable and will not trade the right to press freedom and free speech for a piece of cake.

If you like what we do, and are ready to uphold solutions journalism, kindly donate to the Ripples Nigeria cause.

Your support would help to ensure that citizens and institutions continue to have free access to credible and reliable information for societal development.

Donate Now